Clinical Trials: Design, Conduct, and AnalysisOxford University Press, 1986 - 469 pages The definitive reference work on clinical trials, this book presents a wealth of detailed, practical information on the design, conduct, and analysis of both single center and multicenter trials. No other book on clinical trials offers as much detail as Meinert does on such issues as sample size calculation, stratification and randomization, data systems design, consent form development, publication policies, preparation of funding requests, and reporting procedures. |
From inside the book
Results 1-5 of 51
Page vii
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page xii
... calculations as planning guides the practice of medicine 9.3 Specifications for sample size calculations 7.1 Introduction 9.3.1 Number of treatment groups 7.2 Factors influencing treatment acceptance 9.3.2 Outcome measure 9.3.3 Follow ...
... calculations as planning guides the practice of medicine 9.3 Specifications for sample size calculations 7.1 Introduction 9.3.1 Number of treatment groups 7.2 Factors influencing treatment acceptance 9.3.2 Outcome measure 9.3.3 Follow ...
Page xiii
... calculation illustrations 9.6.1 Illustration 1 : Sample size 10.8.1 Illustration 1 : Restricted randomization using a calculation using chi - square table of random and inverse sine transform approximation permutations 10.8.2 ...
... calculation illustrations 9.6.1 Illustration 1 : Sample size 10.8.1 Illustration 1 : Restricted randomization using a calculation using chi - square table of random and inverse sine transform approximation permutations 10.8.2 ...
Page xiv
... calculation items addressed in the study plan 12.5.8 Instruction items 12.5.9 Time and date items 11.3 Objective and specific aims 12.5.10 Birthdate and age items 11.4 The treatment plan 12.5.11 Identifying items 11.5 Composition of the ...
... calculation items addressed in the study plan 12.5.8 Instruction items 12.5.9 Time and date items 11.3 Objective and specific aims 12.5.10 Birthdate and age items 11.4 The treatment plan 12.5.11 Identifying items 11.5 Composition of the ...
Page xviii
... Calculation items F.16 Instruction items Appendix A. Glossary F.17 Age and birthdate items A.1 Preface F.18 Reminder and documentation A.2 Glossary items F.19 Full - page versus two - column Appendix B. Sketches of selected trials ...
... Calculation items F.16 Instruction items Appendix A. Glossary F.17 Age and birthdate items A.1 Preface F.18 Reminder and documentation A.2 Glossary items F.19 Full - page versus two - column Appendix B. Sketches of selected trials ...
Contents
A stateof | 1 |
223 | 12 |
The activities of | 18 |
Cost and related issues | 40 |
masked allocation | 90 |
Use of items from other | 119 |
Patient recruitment | 149 |
Patient followup | 185 |
randomization | 219 |
Essential management | 232 |
Preparation of | 264 |
Appendix H Budget summary | 279 |
Other editions - View all
Common terms and phrases
Abstract summaries advisory-review allocation ratio Aspirin assess baseline Chapter clinical trial close-out consent control treatment Coronary Drug Project cost data center data collection data coordinating center data dredging data entry data forms database disease Drug Project Research Fisher's exact test follow-up visit funding Gallstone Group Diabetes Program Hypertension Institute investigators laboratory masked ment methods monitoring committee multicenter trials myocardial infarction NCGS needed niacin number of patients outcome measure p-value paper patient recruitment patients enrolled phenformin physician placebo procedures Program Research Group Project Research Group protocol publication Question randomization records responsible safety monitoring sample sample size schedule Section specified sponsor study treatments subgroups TEMC test treatment tients tion tolbutamide treat treatment allocation treatment assignment treatment effects monitoring treatment group treatment monitoring trial involving trials sketched UGDP University Group Diabetes variable Yes Yes Yes